Tipsheet
What matters at India’s listed companies
Trading · Micro cap

Integrated Proteins approves 1:10 split as board reshuffles

Nano-cap board approves stock split to boost liquidity; three directors resign, new appointments follow. Promoter reclassification also approved.

3 earlier stories on Integrated Proteins Ltd.
Mkt cap₹279 cr
ROE1.24%
Debt / eq.0.19
1:10 Stock split ratio approved by board

What's new

  • Board approved 1:10 stock split, subdividing ₹10 face value to Re 1.
  • Three directors resigned, including executive director Vinod Mehta.
  • Three new directors appointed; committees reconstituted.

Why this matters

For a ₹279-cr nano-cap with a P/E of 1233 and trailing revenue down 73.5%, a stock split is a liquidity move. But the simultaneous departure of an executive director and promoter reclassification add governance flux after last month's MD exit.

What we're watching

  • Shareholder and regulatory approvals for the split and record date.
  • Whether the new directors bring stability after recent MD exit.
  • Any impact on control from promoter reclassification to public status.

The full read

Integrated Proteins approved a 1:10 stock split. Each ₹10 share becomes ten Re 1. Goal: liquidity. But fundamentals are weak — trailing revenue down 73.5%, latest quarterly sales ₹6 cr, zero net profit, P/E 1233. Three directors resigned, including executive director Vinod Mehta. Immediate replacements appointed. Promoter reclassification okayed. Hardly a growth story. For a company with ₹0 cr net profit in the March quarter, the split is a liquidity tool, not a value signal. The board churn follows last month's MD exit. The new directors must show stability quickly.

Questions answered

What is the 1:10 stock split?
Each ₹10 share will be subdivided into ten shares of Re 1 each. The split is subject to shareholder and regulatory approvals; the record date will be set later.
Who resigned from the board?
Three directors resigned: Priyansh Tejas Parekh (Independent Director), Neepa Praful Kothari (Non-Executive Director), and Vinod Prabhulal Mehta (Executive Director). All cited professional commitments and personal reasons.
Who were appointed as new directors?
Nitesh Pratapray Mehta and Hiren Dhirajlal Shah as Additional Executive Directors, and Sandeep Mahadik as Additional Independent Director for a five-year term.
What is the promoter reclassification?
Ten individuals, including Vinod Prabhulal Mehta (1.72% stake), requested reclassification from promoter to public status. The board approved it, subject to BSE's no-objection certificate.
Why is the stock split significant for this company?
Integrated Proteins has a market cap of ₹279 cr with low liquidity. A stock split typically makes shares more affordable for retail investors, potentially improving trading volumes.
Mentioned: Integrated Proteins Ltd. · 1:10 stock split · Vinod Prabhulal Mehta · BSE
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Integrated Proteins Ltd.

Miscellaneous
₹277 cr

Latest quarter · Mar 2026

Sales₹6 cr
Net profit₹0 cr
Op. margin+4.0%
EPS₹0.10

Strength & growth

Debt / equity0.19×
Current ratio2.64×
Sales CAGR+115.8%
EPS CAGR+25.2%
  1. 9 Jul 2026 · 8:44 PM IST Integrated Proteins approves 1:10 split as board reshuffles
  2. 10d ago Integrated Proteins board to consider stock split on July 3
  3. 11d ago Integrated Proteins loses MD with immediate effect
  4. 45d ago Integrated Proteins revenue drops 54% in FY26